Surgery Partners, Inc. (NASDAQ:SGRY) Given Average Recommendation of “Moderate Buy” by Analysts

Shares of Surgery Partners, Inc. (NASDAQ:SGRY) have been given an average recommendation of “Moderate Buy” by the ten analysts that are covering the firm, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1-year price objective among analysts that have covered the stock in the last year is $36.56.

SGRY has been the topic of a number of research analyst reports. UBS Group started coverage on Surgery Partners in a research note on Monday, October 14th. They issued a “buy” rating and a $38.00 target price on the stock. Cantor Fitzgerald reiterated an “overweight” rating and issued a $43.00 target price on shares of Surgery Partners in a research note on Friday, October 4th. Macquarie reissued an “outperform” rating and set a $34.00 price objective on shares of Surgery Partners in a research note on Tuesday, November 19th. KeyCorp initiated coverage on Surgery Partners in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. Finally, JPMorgan Chase & Co. cut their price objective on Surgery Partners from $38.00 to $28.00 and set a “neutral” rating for the company in a report on Tuesday, December 3rd.

Institutional Trading of Surgery Partners

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Bank of New York Mellon Corp increased its stake in shares of Surgery Partners by 12.4% in the second quarter. Bank of New York Mellon Corp now owns 347,485 shares of the company’s stock worth $8,267,000 after buying an additional 38,285 shares during the period. Natixis Advisors LLC increased its position in shares of Surgery Partners by 11.0% in the second quarter. Natixis Advisors LLC now owns 12,452 shares of the company’s stock valued at $296,000 after acquiring an additional 1,237 shares during the period. Rhumbline Advisers raised its stake in shares of Surgery Partners by 19.6% during the second quarter. Rhumbline Advisers now owns 127,952 shares of the company’s stock valued at $3,044,000 after acquiring an additional 20,963 shares during the last quarter. Arizona State Retirement System boosted its holdings in shares of Surgery Partners by 1.9% during the second quarter. Arizona State Retirement System now owns 19,494 shares of the company’s stock worth $464,000 after purchasing an additional 359 shares during the period. Finally, Dimensional Fund Advisors LP grew its stake in shares of Surgery Partners by 26.7% in the second quarter. Dimensional Fund Advisors LP now owns 2,801,091 shares of the company’s stock worth $66,643,000 after purchasing an additional 589,499 shares during the last quarter.

Surgery Partners Stock Up 0.5 %

Shares of SGRY opened at $20.64 on Wednesday. The company has a market capitalization of $2.62 billion, a PE ratio of -43.00, a PEG ratio of 17.40 and a beta of 2.58. Surgery Partners has a 12 month low of $19.50 and a 12 month high of $35.29. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.99. The stock’s 50-day moving average price is $23.67 and its two-hundred day moving average price is $27.44.

Surgery Partners (NASDAQ:SGRY) last issued its earnings results on Tuesday, November 12th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.06). The company had revenue of $770.40 million for the quarter, compared to the consensus estimate of $768.99 million. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The firm’s revenue was up 14.3% compared to the same quarter last year. During the same period in the prior year, the company earned $0.15 earnings per share. On average, analysts anticipate that Surgery Partners will post 0.71 EPS for the current year.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.